ABT 8-K 2026-07-16

ABBOTT LABORATORIES (ABT) 8-K dated 2026-07-16 — accession 0001628280-26-048377. This URL is the filing, not the ABT hub.

ABBOTT LABORATORIES (ABT) is a medical devices company listed on NYSE.

ABT to acquire platform ($110M)

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B.

Not investment advice. The ABT SEC hub lists recent forms. The stock page is the research view.